We advise mid-market corporations in Europe, and private equity investors throughout the entire M&A like Mergers and acquisitions advisory deal lifecycle. Get for more info Contact us.
All of us who had welcomed 2020 with lots of hope and spirit were caught off-guarded by the novel Corona Virus – 2019 (COVID19). While most viruses are responsible for common cold and flu, the COVID19 declared as a pandemic by the World Health Organization (WHO) has all set to disrupt both health and global wealth!
The global equity indices of MSCI World, S&P 500, and STOXX Europe 600 have been wavering within short period time in a matter of weeks with a record high on February 19, 2020 to a low on March 18, 2020 and rising back again in June-2020.
The impact on M&A landscape is no exception with deals values down by more than 30% compared to previous years which has brought a definite strategy switch for addressing distressed assets in the wake of COVID -19. The last quarter inscribed a whopping $2.